Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2013

Open Access 01-12-2013 | Research article

Systematic review of genome-wide gene expression studies of bipolar disorder

Authors: Fayaz Seifuddin, Mehdi Pirooznia, Jennifer T Judy, Fernando S Goes, James B Potash, Peter P Zandi

Published in: BMC Psychiatry | Issue 1/2013

Login to get access

Abstract

Background

Numerous genome-wide gene expression studies of bipolar disorder (BP) have been carried out. These studies are heterogeneous, underpowered and use overlapping samples. We conducted a systematic review of these studies to synthesize the current findings.

Methods

We identified all genome-wide gene expression studies on BP in humans. We then carried out a quantitative mega-analysis of studies done with post-mortem brain tissue. We obtained raw data from each study and used standardized procedures to process and analyze the data. We then combined the data and conducted three separate mega-analyses on samples from 1) any region of the brain (9 studies); 2) the prefrontal cortex (PFC) (6 studies); and 3) the hippocampus (2 studies). To minimize heterogeneity across studies, we focused primarily on the most numerous, recent and comprehensive studies.

Results

A total of 30 genome-wide gene expression studies of BP done with blood or brain tissue were identified. We included 10 studies with data on 211 microarrays on 57 unique BP cases and 229 microarrays on 60 unique controls in the quantitative mega-analysis. A total of 382 genes were identified as significantly differentially expressed by the three analyses. Eleven genes survived correction for multiple testing with a q-value < 0.05 in the PFC. Among these were FKBP5 and WFS1, which have been previously implicated in mood disorders. Pathway analyses suggested a role for metallothionein proteins, MAP Kinase phosphotases, and neuropeptides.

Conclusion

We provided an up-to-date summary of results from gene expression studies of the brain in BP. Our analyses focused on the highest quality data available and provided results by brain region so that similarities and differences can be examined relative to disease status. The results are available for closer inspection on-line at Metamoodics [http://​metamoodics.​igm.​jhmi.​edu/​], where investigators can look up any genes of interest and view the current results in their genomic context and in relation to leading findings from other genomic experiments in bipolar disorder.
Appendix
Available only for authorised users
Literature
1.
Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen H, Yeh EK: Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996, 276 (4): 293-299. 10.1001/jama.1996.03540040037030.CrossRefPubMed
2.
Eaton WW, Martins SS, Nestadt G, Bienvenu OJ, Clarke D, Alexandre P: The burden of mental disorders. Epidemiol Rev. 2008, 30: 1-14. 10.1093/epirev/mxn011.CrossRefPubMedPubMedCentral
3.
Craddock N, Forty L: Genetics of affective (mood) disorders. Eur J Hum Genet. 2006, 14 (6): 660-668. 10.1038/sj.ejhg.5201549.CrossRefPubMed
4.
Craddock N, Khodel V, Van Eerdewegh P, Reich T: Mathematical limits of multilocus models: the genetic transmission of bipolar disorder. Am J Hum Genet. 1995, 57 (3): 690-702.PubMedPubMedCentral
5.
Bunney WE, Bunney BG, Vawter MP, Tomita H, Li J, Evans SJ, Choudary PV, Myers RM, Jones EG, Watson SJ, Akil H: Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders. Am J Psychiatry. 2003, 160 (4): 657-666. 10.1176/appi.ajp.160.4.657.CrossRefPubMed
6.
Elashoff M, Higgs BW, Yolken RH, Knable MB, Weis S, Webster MJ, Barci BM, Torrey EF: Meta-analysis of 12 genomic studies in bipolar disorder. J Mol Neurosci. 2007, 31 (3): 221-243.PubMed
7.
Konradi C, Sillivan SE, Clay HB: Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol Dis. 2012, 45 (1): 37-47. 10.1016/j.nbd.2011.01.025.CrossRefPubMed
8.
9.
Leonard S, Logel J, Luthman D, Casanova M, Kirch D, Freedman R: Biological stability of mRNA isolated from human postmortem brain collections. Biol Psychiatry. 1993, 33 (6): 456-466. 10.1016/0006-3223(93)90174-C.CrossRefPubMed
10.
Iwamoto K, Bundo M, Kato T: Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet. 2005, 14 (2): 241-253.CrossRefPubMed
11.
Barrett T, Troup DB, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Muertter RN, Holko M, Ayanbule O, Yefanov A, Soboleva A: NCBI GEO: archive for functional genomics data sets–10 years on. Nucleic Acids Res. 2011, 39 (Database issue): D1005-D1010.CrossRefPubMed
12.
Parkinson H, Kapushesky M, Shojatalab M, Abeygunawardena N, Coulson R, Farne A, Holloway E, Kolesnykov N, Lilja P, Lukk M, Mani R, Rayner T, Sharma A, William E, Sarkans U, Brazma A: ArrayExpress–a public database of microarray experiments and gene expression profiles. Nucleic Acids Res. 2007, 35 (Database issue): D747-D750.CrossRefPubMed
13.
Ramasamy A, Mondry A, Holmes CC, Altman DG: Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS Med. 2008, 5 (9): e184-10.1371/journal.pmed.0050184.CrossRefPubMedPubMedCentral
14.
Hubbell E, Liu WM, Mei R: Robust estimators for expression analysis. Bioinformatics. 2002, 18 (12): 1585-1592. 10.1093/bioinformatics/18.12.1585.CrossRefPubMed
15.
Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003, 4 (2): 249-264. 10.1093/biostatistics/4.2.249.CrossRefPubMed
16.
Wu Z, Irrizary R, Genteman R, Martinez-Murillo F, Spencer F: A model based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc. 2004, 99 (468): 909-917. 10.1198/016214504000000683.CrossRef
17.
Li C, Wong WH: Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA. 2001, 98 (1): 31-36. 10.1073/pnas.98.1.31.CrossRefPubMed
18.
Affymetrix: Guide to probe logarithmic intensity error (PLIER) estimation. Technical Note. 2005, 154 (3): 477-
19.
McCall MN, Irizarry RA: Thawing frozen robust multi-array analysis (fRMA). BMC Bioinforma. 2011, 12: 369-2105-12-369-
20.
Development Core Team: R: A language and environment for statistical computing. 2010, Vienna, Austria: R Foundation for Statistical Computing, http://​www.​R-project.​org, 3-900051-07-0,
21.
22.
23.
Becker RA, Chambers JM: S: An Interactive Environment for Data Analysis and Graphics: Pacific Grove. 1984, CA, USA: Wadsworth & Brooks/Cole
24.
Proceedings of the PANP - a New Method of Gene Detection on Oligonucleotide Expression Arrays Proceedings of the 7th IEEE International Conference on Bioinformatics and Bioengineering, BIBE: October 14–17; Harvard Medical School. Edited by: Warren P, Taylor D, Martini PGV, Jackson J, Bienkowska JR. 2007, Boston, MA, USA: BIBE
25.
Boguski MS, Lowe TM: Tolstoshev CM: dbEST–database for "expressed sequence tags". Nat Genet. 1993, 4 (4): 332-333. 10.1038/ng0893-332.CrossRefPubMed
26.
Liu G, Loraine AE, Shigeta R, Cline M, Cheng J, Valmeekam V, Sun S, Kulp D, Siani-Rose MA: NetAffx: Affymetrix probesets and annotations. Nucleic Acids Res. 2003, 31 (1): 82-86. 10.1093/nar/gkg121.CrossRefPubMedPubMedCentral
27.
Flicek P, Ahmed I, Amode MR, Barrell D, Beal K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fairley S, Fitzgerald S, Gil L, Garcia-Giron C, Gordon L, Hourlier T, Hunt S, Juettemann T, Kahari AK, Keenan S, Komorowska M, Kulesha E, Longden I, Maurel T, McLaren WM, Muffato M, Nag R, Overduin B, Pignatelli M, Pritchard B, Pritchard E, et al: Ensembl 2013. Nucleic Acids Res. 2013, 41 (Database issue): D48-D55.CrossRefPubMed
28.
Oeder S, Mages J, Flicek P, Lang R: Uncovering information on expression of natural antisense transcripts in Affymetrix MOE430 datasets. BMC Genomics. 2007, 8: 200-10.1186/1471-2164-8-200.CrossRefPubMedPubMedCentral
29.
Warren P: panp: Presence-Absence Calls from Negative Strand Matching Probesets. R package version 1.26.0. 2007
30.
Leek JT, Storey JD: Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet. 2007, 3 (9): 1724-1735.CrossRefPubMed
31.
Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD: The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012, 28 (6): 882-883. 10.1093/bioinformatics/bts034.CrossRefPubMedPubMedCentral
32.
Pirooznia M, Seifuddin F, Goes FS, Leek JT, Zandi PP: SVAw - a web-based application tool for automated surrogate variable analysis of gene expression studies. Source Code Biol Med. 2013, 8 (1): 8-10.1186/1751-0473-8-8.CrossRefPubMedPubMedCentral
33.
Stalteri MA, Harrison AP: Interpretation of multiple probe sets mapping to the same gene in Affymetrix GeneChips. BMC Bioinforma. 2007, 8: 13-10.1186/1471-2105-8-13.CrossRef
34.
Li Q, Birkbak NJ, Gyorffy B, Szallasi Z, Eklund AC: Jetset: selecting the optimal microarray probe set to represent a gene. BMC Bioinforma. 2011, 12: 474-2105-12-474-
35.
Baayen R, Davidson DJBD: Mixed-effects modeling with crossed random effects for subjects and items. J Mem Lang. 2008, 59 (4): 390-412. 10.1016/j.jml.2007.12.005.CrossRef
36.
37.
38.
Jurata LW, Bukhman YV, Charles V, Capriglione F, Bullard J, Lemire AL, Mohammed A, Pham Q, Laeng P, Brockman JA, Altar CA: Comparison of microarray-based mRNA profiling technologies for identification of psychiatric disease and drug signatures. J Neurosci Methods. 2004, 138 (1–2): 173-188.CrossRefPubMed
39.
da Huang W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009, 4 (1): 44-57.CrossRefPubMed
40.
da Huang W, Sherman BT, Lempicki RA: Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37 (1): 1-13. 10.1093/nar/gkn923.CrossRefPubMed
41.
Becker KG, White SL, Muller J, Engel J: BBID: the biological biochemical image database. Bioinformatics. 2000, 16 (8): 745-746. 10.1093/bioinformatics/16.8.745.CrossRefPubMed
42.
Kanehisa M: The KEGG database. Novartis Found Symp. 2002, 247: 91-101. discussion 101–3, 119–28, 244–52CrossRefPubMed
43.
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000, 25 (1): 25-29. 10.1038/75556.CrossRefPubMedPubMedCentral
44.
Beech RD, Lowthert L, Leffert JJ, Mason PN, Taylor MM, Umlauf S, Lin A, Lee JY, Maloney K, Muralidharan A, Lorberg B, Zhao H, Newton SS, Mane S, Epperson CN, Sinha R, Blumberg H, Bhagwagar Z: Increased peripheral blood expression of electron transport chain genes in bipolar depression. Bipolar Disord. 2010, 12 (8): 813-824. 10.1111/j.1399-5618.2010.00882.x.CrossRefPubMedPubMedCentral
45.
Benes FM, Matzilevich D, Burke RE, Walsh J: The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol Psychiatry. 2006, 11 (3): 241-251. 10.1038/sj.mp.4001758.CrossRefPubMed
46.
Bernard R, Kerman IA, Thompson RC, Jones EG, Bunney WE, Barchas JD, Schatzberg AF, Myers RM, Akil H, Watson SJ: Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry. 2011, 16 (6): 634-646. 10.1038/mp.2010.44.CrossRefPubMed
47.
Bezchlibnyk YB, Wang JF, McQueen GM, Young LT: Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex. J Neurochem. 2001, 79 (4): 826-834.CrossRefPubMed
48.
Bousman CA, Chana G, Glatt SJ, Chandler SD, Lucero GR, Tatro E, May T, Lohr JB, Kremen WS, Tsuang MT, Everall IP: Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples. Am J Med Genet B Neuropsychiatr Genet. 2010, 153B (2): 494-502.PubMed
49.
Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T: Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry. 2004, 9 (4): 406-416. 10.1038/sj.mp.4001437.CrossRefPubMed
50.
Li JZ, Vawter MP, Walsh DM, Tomita H, Evans SJ, Choudary PV, Lopez JF, Avelar A, Shokoohi V, Chung T, Mesarwi O, Jones EG, Watson SJ, Akil H, Bunney WE, Myers RM: Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet. 2004, 13 (6): 609-616. 10.1093/hmg/ddh065.CrossRefPubMed
51.
Liu C, Cheng L, Badner JA, Zhang D, Craig DW, Redman M, Gershon ES: Whole-genome association mapping of gene expression in the human prefrontal cortex. Mol Psychiatry. 2010, 15 (8): 779-784. 10.1038/mp.2009.128.CrossRefPubMedPubMedCentral
52.
MacDonald ML, Naydenov A, Chu M, Matzilevich D, Konradi C: Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. Bipolar Disord. 2006, 8 (3): 255-264. 10.1111/j.1399-5618.2006.00302.x.CrossRefPubMedPubMedCentral
53.
Matigian N, Windus L, Smith H, Filippich C, Pantelis C, McGrath J, Mowry B, Hayward N: Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway. Mol Psychiatry. 2007, 12 (9): 815-825. 10.1038/sj.mp.4001998.CrossRefPubMed
54.
Matthews PR, Eastwood SL, Harrison PJ: Reduced myelin basic protein and actin-related gene expression in visual cortex in schizophrenia. PLoS One. 2012, 7 (6): e38211-10.1371/journal.pone.0038211.CrossRefPubMedPubMedCentral
55.
Middleton FA, Pato CN, Gentile KL, McGann L, Brown AM, Trauzzi M, Diab H, Morley CP, Medeiros H, Macedo A, Azevedo MH, Pato MT: Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am J Med Genet B Neuropsychiatr Genet. 2005, 136B (1): 12-25. 10.1002/ajmg.b.30171.CrossRefPubMed
56.
Nakatani N, Hattori E, Ohnishi T, Dean B, Iwayama Y, Matsumoto I, Kato T, Osumi N, Higuchi T, Niwa S, Yoshikawa T: Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation. Hum Mol Genet. 2006, 15 (12): 1949-1962. 10.1093/hmg/ddl118.CrossRefPubMed
57.
Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, Bahn S: Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry. 2006, 11 (10): 965-978. 10.1038/sj.mp.4001875.CrossRefPubMed
58.
Sequeira A, Gwadry FG, Ffrench-Mullen JM, Canetti L, Gingras Y, Casero RA, Rouleau G, Benkelfat C, Turecki G: Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry. 2006, 63 (1): 35-48. 10.1001/archpsyc.63.1.35.CrossRefPubMed
59.
Sequeira A, Morgan L, Walsh DM, Cartagena PM, Choudary P, Li J, Schatzberg AF, Watson SJ, Akil H, Myers RM, Jones EG, Bunney WE, Vawter MP: Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide. PLoS One. 2012, 7 (4): e35367-10.1371/journal.pone.0035367.CrossRefPubMedPubMedCentral
60.
Shao L, Vawter MP: Shared gene expression alterations in schizophrenia and bipolar disorder. Biol Psychiatry. 2008, 64 (2): 89-97. 10.1016/j.biopsych.2007.11.010.CrossRefPubMedPubMedCentral
61.
Sheng G, Demers M, Subburaju S, Benes FM: Differences in the circuitry-based association of copy numbers and gene expression between the hippocampi of patients with schizophrenia and the hippocampi of patients with bipolar disorder. Arch Gen Psychiatry. 2012, 69 (6): 550-561. 10.1001/archgenpsychiatry.2011.1882.CrossRefPubMed
62.
Sun X, Wang JF, Tseng M, Young LT: Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J Psychiatry Neurosci. 2006, 31 (3): 189-196.PubMedPubMedCentral
63.
Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S: Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 2003, 362 (9386): 798-805. 10.1016/S0140-6736(03)14289-4.CrossRefPubMed
64.
Tsuang MT, Nossova N, Yager T, Tsuang MM, Guo SC, Shyu KG, Glatt SJ, Liew CC: Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am J Med Genet B Neuropsychiatr Genet. 2005, 133B (1): 1-5. 10.1002/ajmg.b.30161.CrossRefPubMed
65.
Pirooznia M, Nagarajan V, Deng Y: GeneVenn - A web application for comparing gene lists using Venn diagrams. Bioinformation. 2007, 1 (10): 420-422. 10.6026/97320630001420.CrossRefPubMedPubMedCentral
66.
Strakowski SM, Adler CM, Almeida J, Altshuler LL, Blumberg HP, Chang KD, DelBello MP, Frangou S, McIntosh A, Phillips ML, Sussman JE, Townsend JD: The functional neuroanatomy of bipolar disorder: a consensus model. Bipolar Disord. 2012, 14 (4): 313-325. 10.1111/j.1399-5618.2012.01022.x.CrossRefPubMed
67.
Kato T: Molecular genetics of bipolar disorder. Neurosci Res. 2001, 40 (2): 105-113. 10.1016/S0168-0102(01)00221-8.CrossRefPubMed
68.
Velders FP, Kuningas M, Kumari M, Dekker MJ, Uitterlinden AG, Kirschbaum C, Hek K, Hofman A, Verhulst FC, Kivimaki M, Van Duijn CM, Walker BR, Tiemeier H: Genetics of cortisol secretion and depressive symptoms: a candidate gene and genome wide association approach. Psychoneuroendocrinology. 2011, 36 (7): 1053-1061. 10.1016/j.psyneuen.2011.01.003.CrossRefPubMedPubMedCentral
69.
Willour VL, Chen H, Toolan J, Belmonte P, Cutler DJ, Goes FS, Zandi PP, Lee RS, MacKinnon DF, Mondimore FM, Schweizer B, DePaulo JR, Gershon ES, McMahon FJ, Potash JB, Bipolar Disorder Phenome Group: Family-based association of FKBP5 in bipolar disorder. Mol Psychiatry. 2009, 14 (3): 261-268. 10.1038/sj.mp.4002141.CrossRefPubMed
70.
Lekman M, Laje G, Charney D, Rush AJ, Wilson AF, Sorant AJ, Lipsky R, Wisniewski SR, Manji H, McMahon FJ, Paddock S: The FKBP5-gene in depression and treatment response–an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort. Biol Psychiatry. 2008, 63 (12): 1103-1110. 10.1016/j.biopsych.2007.10.026.CrossRefPubMedPubMedCentral
71.
Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Putz B, Papiol S, Seaman S, Lucae S, Kohli MA, Nickel T, Kunzel HE, Fuchs B, Majer M, Pfennig A, Kern N, Brunner J, Modell S, Baghai T, Deiml T, Zill P, Bondy B, Rupprecht R, Messer T, Kohnlein O, Dabitz H, Bruckl T, Muller N, Pfister H, Lieb R, et al: Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet. 2004, 36 (12): 1319-1325. 10.1038/ng1479.CrossRefPubMed
72.
Alda M, Turecki G, Grof P, Cavazzoni P, Duffy A, Grof E, Ahrens B, Berghofer A, Muller-Oerlinghausen B, Dvorakova M, Libigerova E, Vojtechovsky M, Zvolsky P, Joober R, Nilsson A, Prochazka H, Licht RW, Rasmussen NA, Schou M, Vestergaard P, Holzinger A, Schumann C, Thau K, Rouleau GA: Association and linkage studies of CRH and PENK genes in bipolar disorder: a collaborative IGSLI study. Am J Med Genet. 2000, 96 (2): 178-181. 10.1002/(SICI)1096-8628(20000403)96:2<178::AID-AJMG11>3.0.CO;2-C.CrossRefPubMed
73.
De Luca V, Tharmalingam S, Kennedy JL: Association study between the corticotropin-releasing hormone receptor 2 gene and suicidality in bipolar disorder. Eur Psychiatry. 2007, 22 (5): 282-287. 10.1016/j.eurpsy.2006.12.001.CrossRefPubMed
74.
Lee KY, Ahn YM, Joo EJ, Chang JS, Kim YS: The association of DUSP6 gene with schizophrenia and bipolar disorder: its possible role in the development of bipolar disorder. Mol Psychiatry. 2006, 11 (5): 425-426. 10.1038/sj.mp.4001807.CrossRefPubMed
75.
Kim SH, Shin SY, Lee KY, Joo EJ, Song JY, Ahn YM, Lee YH, Kim YS: The genetic association of DUSP6 with bipolar disorder and its effect on ERK activity. Prog Neuropsychopharmacol Biol Psychiatry. 2012, 37 (1): 41-49. 10.1016/j.pnpbp.2011.11.014.CrossRefPubMed
76.
Toyota T, Watanabe A, Shibuya H, Nankai M, Hattori E, Yamada K, Kurumaji A, Karkera JD, Detera-Wadleigh SD, Yoshikawa T: Association study on the DUSP6 gene, an affective disorder candidate gene on 12q23, performed by using fluorescence resonance energy transfer-based melting curve analysis on the LightCycler. Mol Psychiatry. 2000, 5 (5): 461-10.1038/sj.mp.4000769. 489–94CrossRefPubMed
77.
Benes FM, Lim B, Matzilevich D, Walsh JP, Subburaju S, Minns M: Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc Natl Acad Sci USA. 2007, 104 (24): 10164-10169. 10.1073/pnas.0703806104.CrossRefPubMedPubMedCentral
78.
Shaltiel G, Maeng S, Malkesman O, Pearson B, Schloesser RJ, Tragon T, Rogawski M, Gasior M, Luckenbaugh D, Chen G, Manji HK: Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania. Mol Psychiatry. 2008, 13 (9): 858-872. 10.1038/mp.2008.20.CrossRefPubMedPubMedCentral
79.
Silberberg G, Lundin D, Navon R, Ohman M: Deregulation of the A-to-I RNA editing mechanism in psychiatric disorders. Hum Mol Genet. 2012, 21 (2): 311-321. 10.1093/hmg/ddr461.CrossRefPubMed
80.
Andreazza AC, Cassini C, Rosa AR, Leite MC, de Almeida LM, Nardin P, Cunha AB, Cereser KM, Santin A, Gottfried C, Salvador M, Kapczinski F, Goncalves CA: Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res. 2007, 41 (6): 523-529. 10.1016/j.jpsychires.2006.07.013.CrossRefPubMed
81.
Machado-Vieira R, Lara DR, Portela LV, Goncalves CA, Soares JC, Kapczinski F, Souza DO: Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study. Eur Neuropsychopharmacol. 2002, 12 (3): 269-272. 10.1016/S0924-977X(02)00029-9.CrossRefPubMed
82.
Smoller JW, Craddock N, Kendler K, Lee PH, Neale BM, Nurnberger JI, Ripke S, Santangelo S, Sullivan PF, Cross-Disorder Group of the Psychiatric Genomics Consortium: Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013, 381 (9875): 1371-1379.CrossRef
83.
Psychiatric GWAS Consortium Bipolar Disorder Working Group: Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet. 2011, 43 (10): 977-983. 10.1038/ng.943.CrossRef
84.
Choi KH, Elashoff M, Higgs BW, Song J, Kim S, Sabunciyan S, Diglisic S, Yolken RH, Knable MB, Torrey EF, Webster MJ: Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays. BMC Psychiatry. 2008, 8: 87-244X-8-87-CrossRef
85.
Chen C, Cheng L, Grennan K, Pibiri F, Zhang C, Badner JA, Gershon ES, Liu C, Members of the Bipolar Disorder Genome Study (BiGS) Consortium: Two gene co-expression modules differentiate psychotics and controls. Mol Psychiatry. 2012, 10.1038/mp.2012.146. Epub ahead of print
86.
Levin ED, Perraut C, Pollard N, Freedman JH: Metallothionein expression and neurocognitive function in mice. Physiol Behav. 2006, 87 (3): 513-518. 10.1016/j.physbeh.2005.11.014.CrossRefPubMed
87.
Eddins D, Petro A, Pollard N, Freedman JH, Levin ED: Mercury-induced cognitive impairment in metallothionein-1/2 null mice. Neurotoxicol Teratol. 2008, 30 (2): 88-95. 10.1016/j.ntt.2007.12.005.CrossRefPubMed
88.
Carrasco J, Penkowa M, Hadberg H, Molinero A, Hidalgo J: Enhanced seizures and hippocampal neurodegeneration following kainic acid-induced seizures in metallothionein-I + II-deficient mice. Eur J Neurosci. 2000, 12 (7): 2311-2322. 10.1046/j.1460-9568.2000.00128.x.CrossRefPubMed
89.
Hidalgo J, Aschner M, Zatta P, Vasak M: Roles of the metallothionein family of proteins in the central nervous system. Brain Res Bull. 2001, 55 (2): 133-145. 10.1016/S0361-9230(01)00452-X.CrossRefPubMed
90.
Schloesser RJ, Huang J, Klein PS, Manji HK: Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology. 2008, 33 (1): 110-133. 10.1038/sj.npp.1301575.CrossRefPubMed
91.
Muda M, Theodosiou A, Gillieron C, Smith A, Chabert C, Camps M, Boschert U, Rodrigues N, Davies K, Ashworth A, Arkinstall S: The mitogen-activated protein kinase phosphatase-3 N-terminal noncatalytic region is responsible for tight substrate binding and enzymatic specificity. J Biol Chem. 1998, 273 (15): 9323-9329. 10.1074/jbc.273.15.9323.CrossRefPubMed
92.
Perez-Santiago J, Diez-Alarcia R, Callado LF, Zhang JX, Chana G, White CH, Glatt SJ, Tsuang MT, Everall IP, Meana JJ, Woelk CH: A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia. J Psychiatr Res. 2012, 46 (11): 1464-1474. 10.1016/j.jpsychires.2012.08.005.CrossRefPubMed
93.
Tripp A, Kota RS, Lewis DA, Sibille E: Reduced somatostatin in subgenual anterior cingulate cortex in major depression. Neurobiol Dis. 2011, 42 (1): 116-124. 10.1016/j.nbd.2011.01.014.CrossRefPubMedPubMedCentral
94.
Gutman DA, Musselman DL, Nemeroff CB: Chapter 11. Neuropeptide Alterations in Depression and Anxiety Disorders. Handbook of Depression and Anxiety. Edited by: Ad SJM, Kasper S, den Boer JA. 2003, New York: Marcel Dekker, Inc., 229-265.
95.
Liu C: Brain expression quantitative trait locus mapping informs genetic studies of psychiatric diseases. Neurosci Bull. 2011, 27 (2): 123-133. 10.1007/s12264-011-1203-5.CrossRefPubMedPubMedCentral
Metadata
Title
Systematic review of genome-wide gene expression studies of bipolar disorder
Authors
Fayaz Seifuddin
Mehdi Pirooznia
Jennifer T Judy
Fernando S Goes
James B Potash
Peter P Zandi
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2013
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/1471-244X-13-213

Other articles of this Issue 1/2013

BMC Psychiatry 1/2013 Go to the issue

Research article

Appraising the need for care in alzheimer’s disease

Research article

Comorbidities in ADHD children treated with methylphenidate: a database study

Research article

A multi-centre cohort study of short term outcomes of hospital treatment for anorexia nervosa in the UK

Research article

Attitudes towards the administration of long-acting antipsychotics: a survey of physicians and nurses

Research article

Influence of psychosocial risk factors on the trajectory of mental health problems from childhood to adolescence: a longitudinal study

Case report

A bipolar disorder patient becoming asymptomatic after adjunctive anti-filiarasis treatment: a case report